Morphine Administration for Analgesia

Primary Route of Administration

The optimal route for morphine administration is oral, using immediate-release formulations for dose titration and controlled-release formulations for maintenance treatment, as recommended by the British Medical Association 1, 2

Start with immediate-release morphine given every 4 hours, with the same dose available for breakthrough pain, and adjust the total daily dose based on how many rescue doses were required in the previous 24 hours, according to the British Medical Association 1, 2
If pain consistently returns before the next scheduled dose, increase the regular dose, as suggested by the British Medical Association 1, 2

If patients cannot take oral medications, the preferred alternative routes are subcutaneous and rectal, as recommended by the British Medical Association 1, 2, 3
The potency ratio of oral to rectal morphine is 1:1, and only use immediate-release formulations rectally, never controlled-release tablets, according to the British Medical Association 1, 2
The potency ratio of oral to subcutaneous morphine is approximately 1:2, and for breakthrough pain, use the same dose as the regular 4-hourly dose, available as often as every hour, as suggested by the British Medical Association and Praxis Medical Insights 1, 2, 4

Subcutaneous morphine may not be practical in patients with generalized edema, soreness, or sterile abscesses, erythema at injection sites, coagulation disorders, or very poor peripheral circulation, as noted by the British Medical Association and Praxis Medical Insights 1, 2, 4
The potency ratio of oral to intravenous morphine is approximately 1:3, and intravenous administration is preferred when immediate-release oral formulations are unavailable and treatment must be started with controlled-release morphine, according to the British Medical Association 1, 2
There is generally no indication for intramuscular morphine in chronic cancer pain, as subcutaneous administration is simpler and less painful, as recommended by the British Medical Association and Praxis Medical Insights 1, 2, 4
Buccal, sublingual, and nebulized routes are not recommended, as there is no evidence of clinical advantage over conventional routes, according to the British Medical Association 1, 2
Other opioids may be preferred for parenteral administration due to greater solubility, such as diamorphine in Britain and hydromorphone elsewhere, as suggested by the British Medical Association 1, 2
For the 20% of patients who do not achieve adequate pain control with standard routes, consider spinal administration of opioids alone or combined with local anesthetics, according to the British Medical Association 1, 2

Morphine is available in rectal suppository form with a 1:1 bioavailability ratio compared to oral administration, meaning the same dose can be used rectally as would be given orally, according to the British Medical Journal 5, 6
The duration of analgesia is equivalent between oral and rectal routes, as reported by the British Medical Journal 6
Only immediate-release morphine formulations should be used rectally—never crush controlled-release tablets for rectal administration, as recommended by the British Medical Journal 6

Oxycodone has historically been available as a rectal suppository formulation, particularly in low-dose combination products, and is used for treating both post-operative pain and cancer pain via the rectal route, according to the British Journal of Cancer 7
Oxycodone's better systemic bioavailability (60-90%) makes it an effective alternative when morphine is not tolerated, as noted by the British Journal of Cancer 7

Rectal administration is the preferred alternative route when patients cannot take oral medications, alongside subcutaneous administration, as suggested by the British Medical Journal 5, 6
Rectal opioids are particularly useful in pediatric postoperative pain management when combined with NSAIDs and acetaminophen, according to Anaesthesia 8, 9
Tramadol is also mentioned as available in rectal formulation for pediatric postoperative pain management, though it is technically a weaker opioid, as reported by Anaesthesia 8, 9
Hydromorphone is available in suppository formulations, providing an alternative to morphine, as stated by the Journal of the National Comprehensive Cancer Network 10